New imaging tracer could spot hidden cancers
NCT ID NCT07671092
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This early-phase study tests a new imaging agent that targets a protein called TROP2, found on many cancer cells. About 40 adults with metastatic bladder, breast, or lung cancer will receive the agent to see where it goes in the body. The goal is to see if this tracer can help doctors better detect and monitor these cancers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- RYZ211 (68Ga-RAYZ-2453) and RYZ212 (177Lu-RAYZ-2453) imaging agents
- What this could lead to
- If successful, this could lead to better imaging methods to detect and monitor certain metastatic cancers, helping doctors see where the cancer is in the body.
- What could go wrong
- This is a very early (phase 0) imaging study with only 40 participants. It is not designed to treat cancer, so it may not lead to any direct benefit for patients. The imaging agents involve radiation, which carries some risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Facility
Christchurch, New Zealand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?